NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - Jaguar Health, Inc. - 5.03 / 5.07 / 7.01 / 9.01

Filed: 2026-04-21 AccNo: 0001193125-26-165120 Size: 192 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
发布时间04/21 11:35 UTC
首次发现04/21 11:36 UTC
热度104.8
重要度58
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 838 字符

Form 8-K - Current report: SEC Accession No. 0001193125-26-165120

Filing Date: 2026-04-21

Accepted: 2026-04-21 07:35:12

Documents: 14

Period of Report: 2026-04-20

Items: Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Jaguar Health, Inc. (Filer) CIK : 0001585608 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 26876729 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d10648d8k.htm iXBRL | 8-K

2 | EX-3.1 | d10648dex31.htm | EX-3.1

3 | EX-99.1 | d10648dex991.htm | EX-99.1

7 | GRAPHIC | g10648g0418052247437.jpg | GRAPHIC